Background: Current guidelines recommend that comatose out-of-hospital cardiac arrest patients with ST-segment elevations (STEs) following return of spontaneous circulation (ROSC) should be referred for an acute coronary angiography. We sought to investigate the diagnostic value of the pre-hospital ROSC-ECG in predicting ST-elevation myocardial infarction (STEMI). Method: ROSC-ECGs of 145 comatose survivors of out-of-hospital cardiac arrest, randomly assigned in the Target Temperature Management trial, were classified according to the current STEMI ECG criteria (third universal definition of myocardial infarction). Results: STEs were present in the pre-hospital ROSC-ECG of 78 (54%) patients. A final diagnosis revealed that 69 (48%) patients had STEMI, 31 (21%) patients had non-STEMI and 45 (31%) patients had no myocardial infarction. STE in ROSC-ECGs had a sensitivity of 74% (95% confidence interval (CI) 62-84), specificity of 65% (95% CI 53-75) and a positive and negative predictive value of 65% (95% CI 54-76) and 73% (95% CI 61-83) in predicting STEMI. Time to ROSC was significantly longer (24 minutes vs. 19 minutes, P=0.02) in STE compared with no STE patients. Percutaneous coronary intervention was successful in 68% versus 36% (P<0.001) of STE compared to no STE patients. No significant difference was found in 180-day mortality rates between STE and no STE patients (36% vs. 30%, P logrank =0.37). Conclusion: The pre-hospital ROSC-ECG is a suboptimal diagnostic tool to predict STEMI and therefore not a sensitive tool for triage to cardiac centres. This supports the incentive of referring all comatose survivors of out-of-hospital cardiac arrest of suspected cardiac origin to a tertiary heart centre with the availability of acute coronary angiography, even in the absence of STEs.
Introduction
Out-of-hospital cardiac arrest (OHCA) is associated with a poor prognosis. Although the overall survival rate has increased in the last decade, only approximately 10% are alive 30 days after OHCA. 1, 2 The most common cause of OHCA is myocardial infarction (MI) and studies have shown that approximately 70% of OHCA patients have coronary lesions. 3, 4 It is, however, currently being discussed whether all OHCA patients benefit from an early invasive strategy and therefore should be referred directly Editor's Choice-Is the pre-hospital ECG after out-of-hospital cardiac arrest accurate for the diagnosis of ST-elevation myocardial infarction? to a cardiac centre. 5, 6 Studies performed in OHCA patients with a presumed cardiac cause of the arrest have shown that ST-segment elevation (STE) is a frequent finding as 31-53% present with STE after return of spontaneous circulation (ROSC). 3, 4, 7, 8 The European and American guidelines for management of acute coronary syndrome recommend acute coronary revascularisation for all patients with ST-elevation myocardial infarction (STEMI). [9] [10] [11] The universal definition of STEMI of the European Society of Cardiology (ESC) is characterised by the presence of STE in the electrocardiogram (ECG) and symptoms of acute myocardial ischaemia and/or a characteristic rise and fall in cardiac biomarkers. 12 The definition is, however, based on patients with the ability to provide anamnestic information to support the para-clinical and diagnostic tools available.
Approximately 80% of survivors of OHCA are comatose after successful resuscitation, which represents a complex population of patients in whom correct and fast triage is vital to provide optimal post-resuscitation care. 11, 13 Information about pre-arrest symptoms is often missing in the pre-hospital setting 14 and the pre-hospital ROSC-ECG is often the only tool available for triage of these patients. The sensitivity of the ROSC-ECG to predict coronary lesions has, however, not been thoroughly validated. We sought to investigate the diagnostic value of the pre-hospital ROSC-ECG to predict acute coronary lesions in the form of STEMI in comatose survivors of OHCA of suspected cardiac origin. We furthermore aimed to assess whether the ROSC-ECG can be used for selecting STEMI patients for a coronary angiography (CAG).
Methods

Study population
Copenhagen University Hospital, Rigshospitalet, is a tertiary heart centre offering a 24-hour cardiology service with accessibility of invasive coronary and surgical intervention. Resuscitated OHCA patients in the central and greater Copenhagen area with presumed cardiac aetiology are admitted to Rigshospitalet, including all patients with STEs in the pre-hospital ECG.
In the period November 2010 to January 2013, a total of 210 comatose survivors of OHCA were admitted to Rigshospitalet. These patients were screened for inclusion in the Target Temperature Management (TTM) trial, which showed no benefit of targeting 33°C over 36°C. 15 The main inclusion criteria in the TTM trial were: OHCA due to presumed cardiac cause and sustained spontaneous circulation ⩾20 minutes after resuscitation, patients with age ⩾18 years and Glasgow coma scale (GCS) score ⩽8 on hospital admission. Patients were excluded by the following criteria: unwitnessed arrest with asystole as the initial rhythm, ROSC to screening time of more than 240 minutes, suspected or known acute extra-cardiac cause of OHCA and a body temperature less than 30°C at admission. A total of 171 (81%) patients fulfilled all inclusion and no exclusion criteria and were randomly assigned in the TTM Trial. The included patients were randomly assigned and underwent a 24-hour therapeutic hypothermia protocol with allocation to a target temperature of either 33°C or 36°C in a 1:1 fashion. Demographics and pre-hospital data were collected according to Utstein criteria 16 and available through the TTM trial database. Angiographic and percutaneous coronary intervention (PCI) results were collected through a dedicated angiography database, the Eastern Danish Heart Registry. In total our study population consisted of 145 eligible comatose OHCA patients with presumed cardiac aetiology, as we excluded patients without available pre-hospital ROSC-ECGs ( Figure 1 ).
Ethics approval
The TTM trial protocol was prepared in accordance with the Declaration of Helsinki and approved by the ethics committee of all participating countries. Informed or proxy consent was obtained from all included patients by either the patients themselves after regaining capacity or by their next of kin and general practitioner according to national legislation. The TTM Trial is registered and accessible through ClinicalTrials.gov (Identifier: NCT01020916).
STEMI analysis in ROSC-ECG
A ROSC-ECG was defined as the first available pre-hospital 12-lead ECG after ROSC. The available ROSC-ECGs were manually analysed and classified according to the current ECG criteria for STEMI. 12 A STE was defined as an elevation at the J-point of ⩾0.1 mV in all leads, except leads V2 and V3 in which an elevation ⩾0.2 mV in men ⩾40 years or an elevation ⩾0.25 mV in men <40 years and ⩾0.15 mV in women was considered significant. When STEs were present in at least two contiguous leads, the ROSC-ECG was classified as STE. The term 'no STE' was defined as the absence of STE in the ROSC-ECG. STE in anterior (V1-V6), inferior (II, III, aVF) and lateral (I, aVL) lead groups were classified as anterior, inferior or lateral STEs for subgroup analysis. Left bundle branch block was not equivalent to STE for the primary analysis.
For classification of ROSC-ECGs with other signs of MI we included ECGs with STE as described above and/or ST-depressions ⩾0.05 mV in at least two contiguous leads and/or T-inversion ⩾0.1 mV in at least two contiguous leads, 12 and based on this patients were classified as either with or without signs of MI in the ROSC-ECG.
Two investigators (IS and SP) experienced in ECG interpretation and measurements, analysed and classified the ROSC-ECGs blinded to angiography results. Two consultant cardiologists working in the field of ischaemic heart disease (IHD), one as an interventional cardiologist, individually and independently adjudicated patients to a final STEMI, non-STEMI and no MI diagnosis based on a combined clinical evaluation consisting of serial ECGs performed after admission, cardiac biomarkers and CAG results. In cases of disagreement a consensus decision was made. The diagnosis was made in accordance with the third universal definition of MI, including a characteristic rise and/or fall in cardiac biomarkers, significant ST-segment T-wave changes for discrimination between STEMI and non-STEMI, development of pathological Q-waves and identification of a suspected fresh intracoronary thrombus by angiography. 12 This validation remained blinded to findings in the ROSC-ECG.
Outcome
Our primary outcome was to examine the ability of STEs in the ROSC-ECG to predict the final STEMI diagnosis. Our secondary outcome was to evaluate the diagnostic value of the ROSC-ECG in finding all MI patients (STEMI and non-STEMI) and based on this to assess the validity of the ROSC-ECG for correct referral of MI patients for an acute CAG and assess whether STE in the ROSC-ECG has a prognostic value in comatose survivors of OHCA.
Statistical analysis
Baseline characteristics were stratified by STE in the ROSC-ECG and by the final diagnosis (STEMI, non-STEMI and no MI). The ability of STE in the ROSC-ECG to predict the final STEMI diagnosis and to identify all MI patients (STEMI and non-STEMI) were expressed as its sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). The proportion of true results, negative and positive, in terms of the final STEMI diagnosis was presented as the accuracy of STE in the ROSC-ECG. For subgroup analyses, PPVs of STE in 171 paƟents were randomized in the TTM-trial 26 
Diagnostic value of STE in the ROSC-ECG
The ROSC-ECG was recorded in a median of 29 minutes (IQR: 22-42) following the OHCA. STE in the ROSC-ECG, 
CAG, left ventricular ejection fraction and survival analysis
The number of acute CAG (<24 hours) performed, total PCI performed and number of successful PCIs were significantly higher in STE versus no STE patients ( Table 2) . Angiographic signs of coronary lesions were found in 86% of all patients who underwent CAG, with the highest prevalence among STEMI patients. The degree of coronary involvement differed between the groups, with a lower prevalence of one-vessel disease in non-STEMI and no MI patients compared to STEMI patients. PCI was performed most frequently in STEMI patients compared with non-STEMI and no MI patients, and the degree of stenosis prior to PCI was also significantly higher in STEMI patients. The proportion of successful PCIs did not differ significantly among the groups; however, the localisation of the culprit lesion, defined as the lesion the interventional cardiologist chose to treat initially differed significantly, with the left anterior descending artery being the most frequent culprit lesion in STEMI patients ( Table 2 ). The protocolised use of anticoagulants in primary PCI patients included 10,000 units of heparin and 500 mg acetylsalicylic acid IV, supplemented by a loading dosage of 60 mg Presugrel by gastric tube, followed by 10 mg daily in patients without contraindications. Thirteen (9%) patients were found to have chronic total occlusions. In seven patients PCI was attempted but was unsuccessful, and in the remaining six no attempt was initiated. Eight patients were considered eligible for coronary artery bypass grafting if neurological recovery was made. Adverse events related to the CAG/PCI procedures included: mors in tabula in three patients (one with prolonged VT with degeneration to pulseless electrical activity (PEA) despite reperfusion, one cardiogenic shock with impella implantation and degeneration to PEA, no acute occlusions found, one with chronic IHD, failed thrombectomy and deterioration to PEA. One patient had a coronary wire perforation, when trying to perform PCI on a chronic occlusion, although no tamponade developed and one patient had no reflow following otherwise successful PCI. Neither stratification by STE in the ROSC-ECG nor stratification by the final diagnosis revealed a significant difference in 180-day mortality rates. Patients classified with STE in the ROSC-ECG had a 180-day mortality rate of 36% compared with 30% in no STE patients (Figure 3) . Similarly, STEMI patients had a 38% 180-day mortality, whereas non-STEMI patients had a 32% and no MI patients a 27% 180-day mortality rate (Figure 3 ).
Discussion
This study found that STEs are frequent in the ROSC-ECG of comatose survivors of OHCA, with 54% of patients fulfilling the STEMI ECG criteria in the pre-hospital setting. A final diagnosis based on ECG after admission, cardiac biomarkers and CAG findings revealed a suboptimal diagnostic value of the ROSC-ECG. We found a low sensitivity (74%) and specificity (65%) of STE in the ROSC-ECG to identify STEMI in comatose OHCA patients of presumed cardiac aetiology. This raises concerns in terms of the ROSC-ECG as a reliable tool for pre-hospital triage after OHCA with regard to STEMI and thereby its ability to differentiate patients with and without a need for direct transfer to an acute CAG. When including other signs of ischaemia such as ST-segment depressions and T-wave inversions, an improved sensitivity of 95% in finding all MI patients (STEMI and non-STEMI) was compromised by a corresponding poor specificity of only 11%.
ROSC-ECG as a diagnostic tool
The finding of a suboptimal diagnostic value of STE in the ROSC-ECG is in accordance with another study, in which a low sensitivity of 67% for acute or recent coronary lesions was found. 17 Two studies emphasised the importance of the ROSC-ECG and found sensitivities of 88% 18 and 93% 20 of STEs to predict recent coronary lesions/acute MI, as defined by angiography results only. The mentioned studies, however, used ECGs performed after admission 17, 20 or first available after ROSC without other details of timing. 18 Only one study assessed pre-hospital ECGs recorded with similar timing (≈30 minutes post-OHCA) to our study; however, we suspect that the stated sensitivity of 88% of STEs to predict acute MI in fact is the PPV, as the data presented yield a sensitivity of STE to predict MI of 77%, 19 similar to our findings. The ECG criteria used for classification of STEMI in some of the studies did not follow the ESC guidelines in detail. An STE in these studies was defined as an elevation of ⩾0.2 mV in all precordial leads, 17, 19, 20 with an unknown effect on the diagnostic accuracy of the post-resuscitation ECG to detect STEMI in the setting of OHCA. As the methodology of listed studies varies considerably, direct comparison is challenging. Future studies are warranted to establish a common definition for MI following OHCA. It should be noted that STEs are also present in approximately 11% of patients suspected for STEMI without OHCA, in whom no culprit lesion can be found. 21 Our study has some advantages due to the fact that we used objective guideline-defined classification criteria for STE and the fact that the entire study population consisted of comatose survivors of OHCA, in whom pre-arrest symptoms such as chest pain are often missing, leaving the ROSC-ECG as the only diagnostic tool for pre-hospital triage. The proportion of comatose survivors of OHCA in other studies was between 86% and 93%. 17, 20 The lower predictive values of STE found for anterior and inferior leads may explain the overall suboptimal diagnostic value of the ROSC-ECG. Our findings are somewhat comparable with results from another study, in which a PPV of 54% with regard to ECG signs of anterior STEMI was found. 22 Another study showed that the STEMI diagnosis could not be confirmed in 45% of patients initially diagnosed with anterior STE, 23 which is comparable to the 39% false-positive anterior STE cases found in our study. The challenge of diagnosing anterior STEMI could be due to individual and gender-based variations of STE, especially in the precordial leads and due to STE in conditions other than MI. 24 Speculative explanations for pre-hospital STE without STEMI include global or regional myocardial ischaemia due to the arrest itself augmented by chronic IHD, myocardial stunning, use of epinephrine or abnormal repolarisation following the OHCA. STEMI cases without pre-hospital STE may be due to later onset of transmural ischaemia, as seen in MI patients without OHCA. The longer time to ROSC in STE compared to no-STE patients may be explained by a higher prevalence of ongoing ischaemia following OHCA, which may lead to a more refractory cardiac arrest. Prospective studies should assess the exact conversion rates of ischaemic ECG signs following OHCA by a protocolised and standardised timing approach. The cause of OHCA was STEMI in 48% of cases in our study, compared to 31-40% found in other studies. 3, 4, 7 We found that 86% of the population who underwent CAG had coronary lesions, which is somewhat higher than findings in other studies, in which angiographic signs of significant coronary artery disease (CAD) were found in 64-74% of OHCA patients. 3, 4, 7 This may be explained by the standard operating procedure that all patients suspected of coronary lesions are directly referred to Copenhagen University Hospital Rigshospitalet according to regional guidelines.
Emergency echocardiograph and highsensitivity troponin
The role of echocardiography (echo) in pre-hospital triage of OHCA patients has yet to be established. Studies have shown that pre-hospital echo can be used to evaluate potentially reversible causes of cardiac arrest. 25, 26 Exclusion of non-cardiac causes of OHCA and identification of regional impaired left ventricular ejection fraction as a supplement to the ROSC-ECG could provide a better approach for prehospital triage and referral for acute CAG. Future studies on the use of pre-hospital echo are warranted in order to provide evidence of an improved diagnostic certainty, as global or regional left ventricular dysfunction may be present even in the absence of acute coronary lesions following OHCA.
High-sensitivity troponins (Hs-Tn) have enabled the measurement of circulating cardiac troponins at lower concentrations, which could be an important tool in the early identification of the cause of OHCA. 27 However, Hs-TnT seems to be a suboptimal diagnostic tool in selecting OHCA patients for emergency CAG, with a sensitivity of 65% and a specificity of 66% in finding recent coronary lesions. 27 For the time being, there is not any conclusive evidence to support the role of Hs-Tn in pre-hospital diagnosis of OHCA patients, and further studies are required to validate their diagnostic value in the pre-hospital setting.
Post-cardiac arrest care
The high prevalence of CAD in comatose OHCA patients presenting with and without STE in the ROSC-ECG suggests a potential important role of acute coronary reperfusion achieving better outcomes. While guidelines recommend referral of patients with STE after OHCA for acute CAG, the topic of acute revascularisation for all OHCA patients, disregarding pre-hospital STE, is currently widely discussed without definite conclusions. [3] [4] [5] [6] [7] 11, 28 Studies reporting favourable survival rates of OHCA patients without STEMI admitted to a tertiary heart centre compared to patients admitted to non-tertiary heart centres support referral of all OHCA patients to a tertiary heart centre with availability of invasive treatment without triage and treatment delay. 11, 29, 30 Severe hypoxic-ischaemic brain injury has, however, been shown to be the main cause of death in comatose OHCA patients 31 and cardiac disorders were the cause of death in only 16% of cases. Death due to a cardiac cause occurred significantly earlier (median: 2 days) than death due to a brain injury (median: 7 days) 31 and may therefore represent a subgroup benefitting from early invasive treatment.
The ILCOR 32 consensus recommendation states that immediate CAG should be considered in all patients with OHCA and ROSC, despite the absence of STE in the ROSC-ECG. Recent recommendations from the EAPCI 11 agree, however, emphasising that a short emergency department or intensive care unit stop in patients without STE in the post-resuscitation ECG should be performed to evaluate the aetiology of the arrest, while patients with STE, depending on comorbidity and cardiac arrest settings, should go directly to the catheterisation laboratory. Our study supports these recommendations with regard to referral to a tertiary heart centre with availability of invasive treatment if indicated; however, it also shows that not all patients with STE in the pre-hospital setting actually have STEMI as the cause of the arrest. It is, therefore, uncertain whether all patients with STE in the ROSC-ECG may benefit from a very rapid invasive strategy.
In the light of the suboptimal diagnostic certainty of the ROSC-ECG, future studies, preferably prospective and randomised, should assess whether a rapid evaluation at a tertiary heart centre on the basis of repeated ECGs after admission, echo, cardiac biomarkers and cerebral computed tomography scans (if extra cardiac causes of the arrest are suspected) would be a better approach in handling all comatose OHCA patients before taking the patient to the catheterisation laboratory. This may avoid detrimental adverse events of emergency CAG with possible PCI of chronic occlusions and use of anticoagulants in the presence of extra cardiac causes of the arrest. CAG may be performed as soon as possible when other causes of the arrest have been excluded.
Limitations
This was a retrospective study involving a selected group of comatose OHCA patients with possibly overrepresentation of CAD, admitted to a tertiary heart centre. These patients were randomly assigned and included in the TTM study trial, which indicates further selection, although it should be noted that the inclusion at the present site was consecutive. Pre-hospital ROSC-ECGs of acceptable quality were available in 85% of the included patients, and based on experience in the present study, a significant beat-to-beat variation in both the character of the perfusing rhythm, QRS morphology and ST-segment deviation could be observed within a single ECG. This further emphasises the need for validation of alternative pre-hospital triage tools in future studies,
